Skip to content

Implementation Effectiveness of a Precision Pharmacy Intervention Strategy Based on Predictive Modeling in Improving Medication Adherence Among Elderly Patients with Chronic Diseases at Home

Study on Home Medication Adherence Management Strategies for Elderly Patients with Chronic Diseases Based on ITHBC Theory: Variable Selection, Prediction Models, and Management Pathways

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119393
Enrollment
Unknown
Registered
2026-02-26
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic disease

Interventions

Intervention group:Leveraging a predictive model to identify high-risk patients with poor adherence, precision interventions in home pharmacy services are implemented based on the ITHBC behavior chang
Control group:Receives only conventional home pharmacy services (such as distributing educational materials and providing routine reminders) without targeted interventions based on the predictive mode
Observational group:None

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Part One: Elderly patients with chronic diseases aged 60 or above. 2.Part Two: (1) Patients who have been clearly diagnosed with one of the chronic diseases: hypertension, type 2 diabetes, coronary heart disease or stroke. (2) Currently taking two or more chronic disease medications for treatment; (3) Older than 60 years old; (4) Be aware of the research purpose and sign the informed consent form; (5) Be capable of independent communication, have a clear consciousness, no cognitive impairment, and be able to accept the assessment of medication compliance and the intervention of pharmacists; Be able to consistently record medication information and monitoring indicators, agree to the researcher's home visit to provide home pharmaceutical care and cooperate with at least six months of follow-up. (6) There is a chronic disease monitoring result for the past month and it is agreed to conduct monitoring during the 6-month follow-up period.

Exclusion criteria

Exclusion criteria: Part One: None Part Two: Patients with malignant tumors, mental disorders, hearing impairments, those unable to communicate independently, those with limited mobility, and those unable to cooperate in completing the research.

Design outcomes

Primary

MeasureTime frame
Medication adherence score;

Secondary

MeasureTime frame
Achievement of chronic disease control targets and laboratory test results including blood pressure, lipid profile, glucose, liver and renal function within the past 3 months;Patient satisfaction score;Patient quality of life score;Direct medical costs for chronic disease and complication management;Accuracy rate;Recall rate;F1 points;The area under the ROC curve;

Countries

China

Contacts

Public ContactWu Mingfen

Beijing Tiantan Hospital, Capital Medical University

wmfling@163.com+86 152 1074 2036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026